NasdaqCM - Delayed Quote USD
Akanda Corp. (AKAN)
18.20 -0.80 (-4.21%)
At close: June 18 at 4:00:02 PM EDT
15.99 -2.21 (-12.14%)
Pre-Market: 9:13:03 AM EDT
Chart Range Bar
Loading chart for AKAN
- Previous Close
19.00 - Open
17.55 - Bid 12.89 x 200
- Ask 22.97 x 200
- Day's Range
17.01 - 18.80 - 52 Week Range
2.30 - 209.23 - Volume
49,271 - Avg. Volume
2,443,377 - Market Cap (intraday)
9.843M - Beta (5Y Monthly) 14.13
- PE Ratio (TTM)
-- - EPS (TTM)
-15,283.89 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View More
Performance Overview
Trailing total returns as of 6/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
AKAN
76.82%
S&P 500 (^GSPC)
9.57%
1-Year Return
AKAN
80.11%
S&P 500 (^GSPC)
25.41%
3-Year Return
AKAN
99.61%
S&P 500 (^GSPC)
70.10%
5-Year Return
AKAN
100.00%
S&P 500 (^GSPC)
80.02%
Statistics
View MoreValuation Measures
As of 6/18/2026
Market Cap
9.84M
Enterprise Value
23.58M
Trailing P/E
0.02
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.21
Price/Book (mrq)
2.21
Enterprise Value/Revenue
90.81
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-44.15%
Return on Equity (ttm)
--
Revenue (ttm)
258.07k
Net Income Avi to Common (ttm)
-46.16M
Diluted EPS (ttm)
-15,283.89
Balance Sheet and Cash Flow
Total Cash (mrq)
503.56k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-5.71M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
3.4600
-20.82%
Mkt Cap 2.025M
Industry Drug Manufacturers—Specialty & Generic
2.2300
+0.45%
Mkt Cap 9.942M
Industry Drug Manufacturers—Specialty & Generic
1.4900
0.00%
Mkt Cap 4.938M
Industry Drug Manufacturers—Specialty & Generic
1.6500
-10.81%
Mkt Cap 4.986M
Industry Drug Manufacturers—Specialty & Generic
1.0900
-16.79%
Mkt Cap 16.449M
Industry Drug Manufacturers—Specialty & Generic
3.5600
-3.78%
Mkt Cap 42.594M
Industry Drug Manufacturers—Specialty & Generic
0.6400
-1.61%
Mkt Cap 25.261M
Industry Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.